Table 1 Baseline demographics, diagnoses, laboratory results, and medications data for normal and ESKD patient groups
Normal Group (n = 85,699) | ESKD Group (n = 5,410) | |
|---|---|---|
DEMOGRAPHICS | ||
Mean Age in years** | 64.5 | 57.9 |
Sex* | ||
Number Female (percent) | 46,456 (54%) | 2,354 (44%) |
Number Male (percent) | 39,182 (46%) | 3,056 (56%) |
Race/Ethnicity* | ||
Number Black (percent) | 5,826 (7%) | 1,147 (21%) |
Number Native American (percent) | 181 (0%) | 110 (2%) |
Number Asian/Pacific Islander (percent) | 1,062 (1%) | 114 (2%) |
Number Hispanic (percent) | 26 (0%) | 55 (1%) |
Number Middle Eastern/Indian (percent) | 490 (1%) | 7 (0%) |
Number White (percent) | 69,294 (81%) | 3,589 (67%) |
Number Biracial (percent) | 45 (0%) | 7 (0%) |
Number Unknown (percent) | 8,754 (10%) | 381 (7%) |
Number with History of Smoking (percent)* | 15,063 (18%) | 2,423 (45%) |
DIAGNOSES | ||
Number with Hypertension (percent)* | 46,502 (54%) | 4,816 (89%) |
Number with Diabetes Mellitus (percent)* | 22,215 (26%) | 3,403 (63%) |
Number with Cardiovascular Disease (percent)* | ||
Coronary Artery Disease | 12,812 (15%) | 2,346 (43%) |
Cerebrovascular Disease (CVA, Stroke) | 5,041 (6%) | 764 (14%) |
Peripheral Vascular Disease | 4,338 (5%) | 1,168 (22%) |
Number with History of Cancer (percent)* | 10,294 (12%) | 767 (14%) |
Number with Hypercholesterolemia (percent)* | 48,716 (57%) | 3,404 (63%) |
Number with History of Urinary Tract Abnormalities (percent)* | 4633 (5%) | 1512 (28%) |
LABORATORY RESULTS | ||
Urine Microalbumin/Creatinine (mg/g)* | ||
Number patients < 30 (percent) | 12,755 (81.7%) | 31 (25.6%) |
Number patients between 30 and 300 (percent) | 2,593 (16.6%) | 40 (33.1%) |
Number of patients > = 300 (percent) | 255 (1.7%) | 50 (41.3%) |
Urine Protein/Creatinine (g/g) (se)* | 0.11 (0.010) | 3.91 (1.247) |
Hemoglobin A1c (g/dL) (se)* | 5.3 (0.008) | 7.2 (0.062) |
Hemoglobin (g/dL) (se)* | 13.4 (0.002) | 10.9 (0.037) |
Serum Calcium (mg/dL) (se)* | 9.4 (0.001) | 8.8 (0.014) |
Serum Cholesterol (mg/dL) (se)* | 182 (0.051) | 159 (1.814) |
Serum Albumin (g/dL) (se)* | 4.1 (0.001) | 3.2 (0.013) |
Serum Phosphorus (mg/dL) (se)* | 3.4 (0.001) | 4.2 (0.034) |
Number of patients Hepatitis C positive (percent)* | 945 (1%) | 237 (4%) |
MEDICATION | ||
Number with any NSAID Use (ibuprofen, naproxen, etc.) (percent)* | 16,459 (19%) | 2,518 (47%) |
Number with any Proton Pump Inhibitor Use (omeprazole, etc.) (percent)* | 9,689 (11%) | 4,031 (75%) |
Number with Bipolar Drug Use (Lithium) (percent)* | 233 (0%) | 28 (1%) |